Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ZELTIQ Aesthetics ZLTQ

Healthcare Medical Devices
"ZELTIQ Aesthetics Inc is a medical technology company. The Company is engaged in developing and commercializing products utilizing its proprietary controlled cooling technology platform."


NDAQ:ZLTQ - Post by User

ZELTIQ Aesthetics > ZLTQ 7/21/14: Thomson Reuters/Verus downgrades ZELTIQ
<< Previous
 Bullboard Posts
User Avatar Image
(2)
•••
Comment by pienteron Jan 10, 2017 12:19pm
81 Views
Post# 25688887

RE:ZLTQ 7/21/14: Thomson Reuters/Verus downgrades ZELTIQ

RE:ZLTQ 7/21/14: Thomson Reuters/Verus downgrades ZELTIQ
In today after corectie 7%. Just announced Best quarter ever.....
<< Previous
 Bullboard Posts
Dealroom for high-potential pre-IPO opportunities